Overview
Euthyroid hyperthyroxinemia refers to elevated serum thyroxine (T4) levels without clinical signs of hyperthyroidism, often observed in patients on high-dose propranolol therapy 1.Diagnosis
Elevated serum free thyroxine (FT4) levels and/or free thyroxine index (FTI) 1.
Low-normal serum triiodothyronine (T3) levels 1.
Elevated serum reverse T3 levels 1.
Normal or blunted TSH response to thyrotropin-releasing hormone (TRH) stimulation 1.
Absence of clinical symptoms of hyperthyroidism despite biochemical abnormalities 1.Management
Consider dose reduction or discontinuation of high-dose propranolol to assess normalization of thyroid function parameters 1.
Monitor thyroid function tests periodically in patients on high-dose propranolol 1.Special Populations
No specific data provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Evaluate thyroid function comprehensively in patients on high-dose propranolol who exhibit elevated serum T4 levels, including FT4, FTI, T3, reverse T3, and TSH response to TRH 1 (Evidence: Moderate).
If euthyroid hyperthyroxinemia is confirmed, consider adjusting propranolol dosage to assess resolution of biochemical abnormalities 1 (Evidence: Moderate).
Regular monitoring of thyroid function tests is advised for patients maintained on high-dose propranolol therapy 1 (Evidence: Expert opinion).References
1 Cooper DS, Daniels GH, Ladenson PW, Ridgway EC. Hyperthyroxinemia in patients treated with high-dose propranolol. The American journal of medicine 1982. link90778-1)